These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5016572)

  • 1. Effect of tissue norepinephrine depletion by 6-hydroxydopamine on blood pressure in spontaneously hypertensive rats.
    Yamori Y; Yamabe H; De Jong W; Lovenberg W; Sjoerdsma A
    Eur J Pharmacol; 1972 Jan; 17(1):135-40. PubMed ID: 5016572
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.
    Breese GR; Traylor TD
    J Pharmacol Exp Ther; 1970 Sep; 174(3):413-20. PubMed ID: 5456173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-hydroxydopamine, 6-hydroxydopa and degeneration of adrenergic nerves.
    de Champlain J; Nadeau R
    Fed Proc; 1971; 30(3):877-85. PubMed ID: 4324975
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of 6-hydroxydopamine on putative transmitter substances in the central nervous system.
    Jacks BR; de Champlain J; Cordeau JP
    Eur J Pharmacol; 1972 May; 18(3):353-60. PubMed ID: 5035623
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue catecholamine concentrations in spontaneously hypertensive rats.
    Wocial B; Chodakowska J; Zukowska-Grójec Z; Rutczyński M; Boratyński W
    Acta Physiol Pol; 1977; 28(4):303-12. PubMed ID: 596180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of cardiac norepinephrine in rats and mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Fuller RW; Hahn RA; Snoddy HD; Wikel JH
    Biochem Pharmacol; 1984 Oct; 33(19):2957-60. PubMed ID: 6333240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of tissue norepinephrine and blood pressure by 3,5-dihydroxy-4-methoxy-phenylalanine.
    Spector S; Tabei R; Creveling CR; Daly JW; Witkop B; Sjoerdsma A
    Life Sci; 1968 Sep; 7(17):943-9. PubMed ID: 5735321
    [No Abstract]   [Full Text] [Related]  

  • 8. Degeneration and regrowth of adrenergic nerve fibers in the rat peripheral tissues after 6-hydroxydopamine.
    de Champlain J
    Can J Physiol Pharmacol; 1971 Apr; 49(4):345-55. PubMed ID: 5124933
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical basis of heart function. 3. Influence of isoproterenol on the norepinephrine stores in the rat heart.
    Dhalla NS; Balasubramanian V; Goldman J
    Can J Physiol Pharmacol; 1971 Apr; 49(4):302-11. PubMed ID: 5124930
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of neonatal 6-hydroxydopamine treatment on the blood pressure response to noradrenaline and tyramine in rats.
    Provoost AP; de Kemp JA; de Jong W
    Eur J Pharmacol; 1973 Sep; 23(3):297-301. PubMed ID: 4746745
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term effects of postnatal 6-hydroxydopamine treatment on tissue catecholamine levels.
    Lytle LD; Shoemaker WJ; Cottman K; Wurtman RJ
    J Pharmacol Exp Ther; 1972 Oct; 183(1):56-64. PubMed ID: 5080034
    [No Abstract]   [Full Text] [Related]  

  • 12. Norepinephrine depleting and antihypertensive effect of 4-methoxy-3,5-dihydroxyphenylalanine.
    Thoenen H; Gerold M; Haefely W; Huerlimann A
    Experientia; 1968 Feb; 24(2):158-9. PubMed ID: 4384506
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of peripherally administered 6-hydroxydopamine on rat brain monoamine turnover.
    Clark WG; Corrodi H; Masuoka DT
    Eur J Pharmacol; 1971 Jun; 15(1):41-4. PubMed ID: 5161339
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood pressure and noradrenaline levels after treatment with alpha-methyldopa, alpha-methyldopamine and alpha-methyl-m-tyrosine.
    Henning M
    J Pharm Pharmacol; 1967 Nov; 19(11):775-9. PubMed ID: 4383705
    [No Abstract]   [Full Text] [Related]  

  • 15. Formation of a "false" adrenergic transmitter in cats pretreated with 4-methyoxy-3,5-dihydroxyphenylalanine and its effects on postganglionic sympathetic transmission.
    Thoenen H; Haefely W; Haeusler G; Huerlimann A
    J Pharmacol Exp Ther; 1968 Jul; 162(1):70-9. PubMed ID: 4297802
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of dopamine-beta-hydroxylase inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
    Ishii Y; Mimura C; Homma M
    J Pharmacol Exp Ther; 1976 Sep; 198(3):589-95. PubMed ID: 988175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced binding of 3 H-reserpine to the hearts of 6-hydroxydopamine-pretreated rats.
    Manara L; Mennini T; Carminati P
    Eur J Pharmacol; 1972 Jan; 17(1):183-5. PubMed ID: 5016581
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of 6-hydroxydopamine on noradrenaline-containing neurones in the rat brain.
    Uretsky NJ; Iversen LL
    Nature; 1969 Feb; 221(5180):557-9. PubMed ID: 5789302
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypothermia induced by intraventricular administration of 6-hydroxydopamine in rats.
    Nakamura K; Thoenen H
    Eur J Pharmacol; 1971 Sep; 16(1):46-54. PubMed ID: 4400511
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of dopamine-beta-hydroxylase inhibition on the cardiovascular and respiratory actions of dopamine in rats.
    Riancho JA; del Arco C; Pazos A; Flórez J
    Rev Esp Fisiol; 1982 Dec; 38(4):461-9. PubMed ID: 7170431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.